Sign in
8-K

Current Report

Allarity Therapeutics, Inc. Filed Acc 0001213900-23-004263

Material agreement · Shareholder rights changed · Regulation FD disclosure

  • Item 1.01 Entry into a material definitive agreement
  • Item 3.03 Material modification to rights of security holders
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading ea172038-8k_allarity.htm…